Ivax Diagnostics CEO and president retires
After 27 years in the position, Giorgio D'Urso is resigning as president and CEO of Ivax Diagnostics, as well as a member of the board of directors of Ivax, effective Jan. 10.
The Miami-based Ivax also said that Kevin D. Clark, its chief operating officer (COO) since September 2007, has been appointed acting CEO, effective from D'Urso's resignation. Clark will remain in that position until the time the company names D'Urso's permanent successor.
In addition to serving as acting CEO, Clark will continue to serve as COO of Ivax and as COO of ImmunoVision, Ivax’s wholly-owned subsidiary which develops, manufactures and markets autoimmune reagents and research products for use by research laboratories and commercial diagnostic manufacturers.
The Miami-based Ivax also said that Kevin D. Clark, its chief operating officer (COO) since September 2007, has been appointed acting CEO, effective from D'Urso's resignation. Clark will remain in that position until the time the company names D'Urso's permanent successor.
In addition to serving as acting CEO, Clark will continue to serve as COO of Ivax and as COO of ImmunoVision, Ivax’s wholly-owned subsidiary which develops, manufactures and markets autoimmune reagents and research products for use by research laboratories and commercial diagnostic manufacturers.